Literature DB >> 21497922

Preserved muscle protein metabolism in obese patients with chronic heart failure.

Roberto Aquilani1, Maria Teresa La Rovere, Oreste Febo, Federica Boschi, Paolo Iadarola, Daniela Corbellini, Simona Viglio, Andria Innocenza Bongiorno, Ornella Pastoris, Manuela Verri.   

Abstract

BACKGROUND: We hypothesized that obese chronic heart failure (CHF) patients, who are known to have less cardiac dysfunction, could show preserved muscle protein balance. The aim of this study was to relate muscle protein balance and cardiac function to body mass index (BMI) in order to provide further insight to the obesity paradox in CHF patients.
METHODS: Thirty stable CHF patients were categorized by BMI (n=6, normal; n=14, overweight; n=10, obese) and underwent post-absorptive: (i) right heart catheterization to determine cardiac hemodynamics and (ii) arterial and venous blood sampling to measure arterial and venous levels of essential amino acids (EAAs) and to calculate arterovenous differences (positive = uptake; negative = release). Muscle protein over-degradation was assessed by muscle release of the EAA phenylalanine. Plasma N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) was also determined. Twenty healthy subjects, matched for age, served as controls and underwent radial artery and vein sampling only.
RESULTS: Obese CHF patients had normal muscle protein balance, muscle EAA release, and arterial EAA concentration. Among the non-obese patients, normally weighted ones had more pronounced muscle protein over-degradation and greater reduction of arterial EAAs (p<0.01 for both) and EAA release (p<0.06) than overweight ones. Arterial leucine levels correlated negatively with NT-pro-BNP (r=-0.75; p<0.0001) and positively with LVEF (r=+0.68; p<0.0001). Within EAAs, branched chain amino acids were positively associated with stroke volume index (r=+0.51; p=0.004).
CONCLUSIONS: Only obese patients with CHF have balanced muscle protein metabolism. This may contribute to explain the obesity paradox.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21497922     DOI: 10.1016/j.ijcard.2011.03.032

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  13 in total

1.  Prognostic value of leucine/phenylalanine ratio as an amino acid profile of heart failure.

Authors:  Hiroaki Hiraiwa; Takahiro Okumura; Toru Kondo; Toshiaki Kato; Shingo Kazama; Yuki Kimura; Toshikazu Ishihara; Etsuo Iwata; Masafumi Shimojo; Sayano Kondo; Soichiro Aoki; Yasunori Kanzaki; Daisuke Tanimura; Hiroaki Sano; Yoshifumi Awaji; Sumio Yamada; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2021-01-22       Impact factor: 2.037

2.  Adiposity facilitates increased strength capacity in heart failure patients with reduced ejection fraction.

Authors:  Alexandra Zavin; Karla Daniels; Ross Arena; Kelly Allsup; Antonio Lazzari; Jacob Joseph; P Christian Schulze; Stewart H Lecker; Daniel E Forman
Journal:  Int J Cardiol       Date:  2012-06-27       Impact factor: 4.164

Review 3.  Obesity and the Survival of Critically Ill Patients with Acute Kidney Injury: A Paradox within the Paradox?

Authors:  Helmut Schiffl
Journal:  Kidney Dis (Basel)       Date:  2019-10-08

Review 4.  Amino acids and derivatives, a new treatment of chronic heart failure?

Authors:  Valentina Carubelli; Anna Isotta Castrini; Valentina Lazzarini; Mihai Gheorghiade; Marco Metra; Carlo Lombardi
Journal:  Heart Fail Rev       Date:  2015-01       Impact factor: 4.214

5.  Factors associated with elevated plasma phenylalanine in patients with heart failure.

Authors:  Chi-Wen Cheng; Min-Hui Liu; Hsiang-Yu Tang; Mei-Ling Cheng; Chao-Hung Wang
Journal:  Amino Acids       Date:  2021-01-04       Impact factor: 3.520

Review 6.  Skeletal muscle protein metabolism in human heart failure.

Authors:  Damien M Callahan; Michael J Toth
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2013-01       Impact factor: 4.294

7.  Presence of obesity is associated with lower mortality in elderly patients with implantable cardioverter defibrillator.

Authors:  A Jahangir; M Mirza; M Shahreyar; T Mengesha; R Shearer; S Sultan; A Jahangir; I Choudhuri; V Nangia; A Dhala; A Bhatia; I Niazi; J Sra; A J Tajik
Journal:  Int J Obes (Lond)       Date:  2017-08-30       Impact factor: 5.095

8.  Unaffected arm muscle hypercatabolism in dysphagic subacute stroke patients: the effects of essential amino acid supplementation.

Authors:  Roberto Aquilani; Mirella Boselli; Giuseppe D'Antona; Paola Baiardi; Federica Boschi; Simona Viglio; Paolo Iadarola; Evasio Pasini; Annalisa Barbieri; Maurizia Dossena; Andria Innocenza Bongiorno; Manuela Verri
Journal:  Biomed Res Int       Date:  2014-11-09       Impact factor: 3.411

9.  Plasma Amino Acid Abnormalities in Chronic Heart Failure. Mechanisms, Potential Risks and Targets in Human Myocardium Metabolism.

Authors:  Roberto Aquilani; Maria Teresa La Rovere; Daniela Corbellini; Evasio Pasini; Manuela Verri; Annalisa Barbieri; Anna Maria Condino; Federica Boschi
Journal:  Nutrients       Date:  2017-11-15       Impact factor: 5.717

10.  Altered Amino Acid Metabolism in Patients with Cardiorenal Syndrome Type 2: Is It a Problem for Protein and Exercise Prescriptions?

Authors:  Roberto Aquilani; Roberto Maestri; Maurizia Dossena; Maria Teresa La Rovere; Daniela Buonocore; Federica Boschi; Manuela Verri
Journal:  Nutrients       Date:  2021-05-13       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.